Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the completion of a $57.5M Series D financing round with leading global investors. Lightstone Ventures and ClavystBio co-led the Series D financing with participation by existing investors NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare, and Brandon Capital.

Allay Therapeutics是一家临床阶段的生物技术公司，致力于开发超长效镇痛产品以变革术后疼痛管理和康复，今天宣布已完成由全球领先投资者参与的5750万美元D轮融资。本轮融资由Lightstone Ventures和ClavystBio领投，现有投资者NEA、Arboretum Ventures、Vertex Growth、Vertex Ventures Healthcare和Brandon Capital也参与其中。

New investors joining the round were IPD Capital, EDBI and SGInnovate, and HSBC Innovation Banking also provided additional venture debt financing to the Company. Allay also announced that Joe Zakrzewski, an experienced pharmaceutical executive, has been appointed Chairman of the Board of Directors, and Anselm Tan of ClavystBio will also join Allay's board, associated with the financing..

新加入此轮融资的投资者包括IPD Capital、EDBI和SGInnovate，汇丰创新银行（HSBC Innovation Banking）还为公司提供了额外的风险债务融资。Allay还宣布，经验丰富的医药行业高管乔·扎克日夫斯基（Joe Zakrzewski）已被任命为董事会主席，ClavystBio的陈安瑟姆（Anselm Tan）也将加入Allay的董事会，与此轮融资相关联。

Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians. Our proprietary technology platform combines validated non-opioid analgesics and biopolymers to create dissolvable candidates to deliver pain relief within a targeted site over weeks: an order of magnitude greater than the longest-lasting pain treatments currently available.

Allay Therapeutics正在开创超持久镇痛产品，以改变患者和医生的术后疼痛管理和恢复。我们的专有技术平台结合了经验证的非阿片类镇痛药和生物聚合物，创造出可溶解的候选药物，能够在目标部位提供数周的疼痛缓解：比目前最持久的疼痛治疗效果高出一个数量级。

Our platform and vision were shaped by The Foundry incubator and Lightstone Venture's Singapore Fund. Allay unites a dynamic, global team of entrepreneurs, scientists, clinicians and innovators in the San Francisco Bay Area and Singapore..

我们的平台和愿景由The Foundry孵化器和Lightstone Venture的新加坡基金塑造。Allay在旧金山湾区和新加坡汇聚了一支充满活力的全球团队，包括企业家、科学家、临床医生和创新者。